https://www.selleckchem.com/pr....oducts/lonafarnib-sc
To examine psychosocial and behavioural impacts of the novel coronavirus disease 2019 (COVID-19) pandemic and lockdown restrictions among adults with type 2 diabetes. Participants enrolled in the PRogrEssion of DIabetic ComplicaTions (PREDICT) cohort study in Melbourne, Australia (n=489 with a baseline assessment pre-202 were invited to complete a phone/online follow-up assessment in mid-2020 (i.e., amidst COVID-19lockdown restrictions). Repeated assessments that were compared with pre-COVID-19 baseline levels included anx
Like
Comment
Share
